Rankings
▼
Calendar
XOMAP Q1 2023 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$437,000
-85.9% YoY
Gross Profit
$383,000
87.6% margin
Operating Income
-$10M
-2327.2% margin
Net Income
-$10M
-2245.5% margin
EPS (Diluted)
$-1.55
QoQ Revenue Growth
-70.6%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$134M
Total Liabilities
$19M
Stockholders' Equity
$115M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$437,000
$3M
-85.9%
Gross Profit
$383,000
$3M
-87.4%
Operating Income
-$10M
-$2M
-392.5%
Net Income
-$10M
-$2M
-330.4%
← FY 2023
All Quarters
Q2 2023 →